KRAS and neoplasm: However, at the time, very little is known about the interrelationship between TILs, MSI, and other tumour molecular features, such as the CpG island methylator phenotype (CIMP), global DNA hypomethylation, and KRAS, BRAF, and PIK3CA mutations.